Analysts Set Beam Therapeutics Inc. (NASDAQ:BEAM) Price Target at $48.75
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been given an average rating of “Buy” by the fifteen analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, eleven have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been given an average rating of “Buy” by the fifteen analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation, eleven have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. […]
